News
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...
In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower ...
Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...
Long Island patients lost vision after taking weight loss drugs Ozempic and Wegovy, lawsuits contend
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Explore more
3d
The Brighterside of News on MSNFirst head-to-head trial compares tirzepatide and semaglutide - Results are in!Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide ...
13h
ZME Science on MSNPatients on Weight Loss Drugs Like Wegovy May Say They Just Don’t Want to Drink AnymoreOn a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...
Experts say the right diet may offer the same effects as Ozempic by curbing hunger and promoting steady weight loss.
Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
2d
Fitgurú on MSNUsing Semaglutide to Shed Pounds? 5 Tips to Boost Its EffectsToday, we're diving into a hot topic in the world of health and wellness: semaglutide. You might have heard about this medication in the context of weight loss. While it's a promising tool, it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results